Literature DB >> 9692756

Differential presynaptic and postsynaptic expression of m1-m4 muscarinic acetylcholine receptors at the perforant pathway/granule cell synapse.

S T Rouse1, M L Gilmor, A I Levey.   

Abstract

A family of muscarinic acetylcholine receptor proteins mediates diverse pre- and postsynaptic functions in the hippocampus. However the roles of individual receptors are not understood. The present study identified the pre- and postsynaptic muscarinic acetylcholine receptors at the perforant pathway synapses in rat brain using a combination of lesioning, immunocytochemistry and electron microscopic techniques. Entorhinal cortex lesions resulted in lamina-specific reductions of m2, m3, and m4 immunoreactivity in parallel with the degeneration of the medial and lateral perforant pathway terminals in the middle and outer thirds of the molecular layer, respectively. In contrast, granule cell lesions selectively reduced m1 and m3 receptors consistent with degeneration of postsynaptic dendrites. Direct visualization of m1-m4 by electron microscopic immunocytochemistry confirmed their differential pre- and postsynaptic localizations. Together, these findings provide strong evidence for both redundancy and spatial selectivity of presynaptic (m2, m3 and m4) and postsynaptic (m1 and m3) muscarinic acetylcholine receptors at the perforant pathway synapse.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692756     DOI: 10.1016/s0306-4522(97)00681-7

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

1.  Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis.

Authors:  Ji-Dong Guo; Rimi Hazra; Joanna Dabrowska; E Chris Muly; Jürgen Wess; Donald G Rainnie
Journal:  Neuropharmacology       Date:  2011-12-08       Impact factor: 5.250

Review 2.  Muscarinic and nicotinic acetylcholine receptor agonists and allosteric modulators for the treatment of schizophrenia.

Authors:  Carrie K Jones; Nellie Byun; Michael Bubser
Journal:  Neuropsychopharmacology       Date:  2011-09-28       Impact factor: 7.853

3.  Preferential localization of muscarinic M1 receptor on dendritic shaft and spine of cortical pyramidal cells and its anatomical evidence for volume transmission.

Authors:  Miwako Yamasaki; Minoru Matsui; Masahiko Watanabe
Journal:  J Neurosci       Date:  2010-03-24       Impact factor: 6.167

4.  Synergistic effects of genetic variation in nicotinic and muscarinic receptors on visual attention but not working memory.

Authors:  P M Greenwood; M-K Lin; R Sundararajan; K J Fryxell; R Parasuraman
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

Review 5.  Synthesis, trafficking, and localization of muscarinic acetylcholine receptors.

Authors:  Neil M Nathanson
Journal:  Pharmacol Ther       Date:  2008-05-16       Impact factor: 12.310

6.  Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells.

Authors:  M J Marino; S T Rouse; A I Levey; L T Potter; P J Conn
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-15       Impact factor: 11.205

7.  Diverse glutamatergic inputs target spines expressing M1 muscarinic receptors in the basolateral amygdala: An ultrastructural analysis.

Authors:  Alexander J McDonald; Grace C Jones; David D Mott
Journal:  Brain Res       Date:  2019-07-23       Impact factor: 3.252

Review 8.  Cholinergic regulation of fear learning and extinction.

Authors:  Marlene A Wilson; Jim R Fadel
Journal:  J Neurosci Res       Date:  2016-10-05       Impact factor: 4.164

9.  Localization of the M2 muscarinic cholinergic receptor in dendrites, cholinergic terminals, and noncholinergic terminals in the rat basolateral amygdala: An ultrastructural analysis.

Authors:  Jay F Muller; Franco Mascagni; Violeta Zaric; David D Mott; Alexander J McDonald
Journal:  J Comp Neurol       Date:  2016-02-08       Impact factor: 3.215

10.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.

Authors:  Michael D Grannan; Catharine A Mielnik; Sean P Moran; Robert W Gould; Jacob Ball; Zhuoyan Lu; Michael Bubser; Amy J Ramsey; Masahito Abe; Hyekyung P Cho; Kellie D Nance; Anna L Blobaum; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2016-10-05       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.